




Searching News Database: acute coronary syndromes
HSMN NewsFeed - 12 Dec 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
HSMN NewsFeed - 9 Jul 2015
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
The Medicines Company Authorizes Generic Launch of ANGIOMAX(R) (bivalirudin)
HSMN NewsFeed - 16 May 2013
InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent
InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent
HSMN NewsFeed - 25 Jul 2011
Medicure Announces Appointment of Dawson Reimer as President and Chief Operating Officer
Medicure Announces Appointment of Dawson Reimer as President and Chief Operating Officer
HSMN NewsFeed - 28 Jul 2010
FDA Advisory Committee Recommends US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes
FDA Advisory Committee Recommends US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes
HSMN NewsFeed - 4 Jan 2010
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
HSMN NewsFeed - 21 May 2009
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
HSMN NewsFeed - 19 May 2009
First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter
First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter
HSMN NewsFeed - 13 May 2009
AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
HSMN NewsFeed - 23 Apr 2009
Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen
Celera Licenses Cardiovascular Biomarkers and Other Intellectual Property from Perlegen
HSMN NewsFeed - 23 Feb 2009
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
HSMN NewsFeed - 3 Feb 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
HSMN NewsFeed - 31 Dec 2008
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
HSMN NewsFeed - 26 Aug 2008
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
ACUITY 1-Year Sub-Analysis Published in Journal of the American College of Cardiology
HSMN NewsFeed - 28 May 2008
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
The Medicines Company Receives FDA Review Letter for Angiomax Supplemental Filing
HSMN NewsFeed - 4 Dec 2007
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
Journal of the American Medical Association (JAMA) Publishes One-Year ACUITY Trial Results
HSMN NewsFeed - 25 Oct 2007
Momenta Pharmaceuticals Announces Appointment of Jo-Ann Beltramello as Vice President, Human Resources
Momenta Pharmaceuticals Announces Appointment of Jo-Ann Beltramello as Vice President, Human Resources
HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
HSMN NewsFeed - 7 Aug 2007
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
The Medicines Company Submits Angiomax(R) (Bivalirudin) sNDA to Expand Label to Include ACUITY Data
HSMN NewsFeed - 2 Jul 2007
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
The Medicines Company Reacquires Angiox(R) (Bivalirudin) Rights in Europe from Nycomed
HSMN NewsFeed - 27 Jun 2007
Beckman Coulter Grants Sublicense to Dade Behring for Novel Cardiac Markers
Beckman Coulter Grants Sublicense to Dade Behring for Novel Cardiac Markers
HSMN NewsFeed - 26 Jun 2007
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
Nuvelo Resumes Development of Alfimeprase in Multiple Blood-Clot Related Indications
HSMN NewsFeed - 24 Apr 2007
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
Journal of the American Medical Association Publishes MERLIN TIMI-36 Results
HSMN NewsFeed - 24 Mar 2007
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
HSMN NewsFeed - 7 Feb 2007
Dr. David D. Waters Joins Anthera Pharmaceuticals as Cardiovascular Research Fellow
Dr. David D. Waters Joins Anthera Pharmaceuticals as Cardiovascular Research Fellow
HSMN NewsFeed - 22 Nov 2006
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
The New England Journal of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results
HSMN NewsFeed - 4 Oct 2006
Arixtra(R) Receives Priority Review by the FDA in Acute Coronary Syndromes (ACS)
Arixtra(R) Receives Priority Review by the FDA in Acute Coronary Syndromes (ACS)
HSMN NewsFeed - 22 Aug 2006
Momenta Pharmaceuticals Announces Appointment of Craig A. Wheeler as Chief Executive Officer
Momenta Pharmaceuticals Announces Appointment of Craig A. Wheeler as Chief Executive Officer
HSMN NewsFeed - 6 Jul 2006
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
HSMN NewsFeed - 29 Jun 2006
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
HSMN NewsFeed - 15 May 2006
Dade Behring Launches CardioPhase(R) hsCRP Test for Use on Its Dimension(R) Systems
Dade Behring Launches CardioPhase(R) hsCRP Test for Use on Its Dimension(R) Systems
HSMN NewsFeed - 19 Apr 2006
FDA Grants Fast Track Designation to Schering-Plough for its Thrombin Receptor Antagonist SCH 530348
FDA Grants Fast Track Designation to Schering-Plough for its Thrombin Receptor Antagonist SCH 530348
HSMN NewsFeed - 11 Apr 2006
Inflammatory-Enzyme Shown to Predict Risk of Cardiovascular Events After Acute Coronary Syndromes
Inflammatory-Enzyme Shown to Predict Risk of Cardiovascular Events After Acute Coronary Syndromes
HSMN NewsFeed - 4 Apr 2006
The Medicines Company Commences Patient Enrollment in Pivotal Phase III Clinical Trial of Cangrelor
The Medicines Company Commences Patient Enrollment in Pivotal Phase III Clinical Trial of Cangrelor
HSMN NewsFeed - 23 Mar 2006
Nuvelo Appoints Shelly D. Guyer Vice President, Business Development and Investor Relations
Nuvelo Appoints Shelly D. Guyer Vice President, Business Development and Investor Relations
HSMN NewsFeed - 12 Mar 2006
Vasogen Announces Results from Phase III SIMPADICO Trial in Peripheral Arterial Disease
Vasogen Announces Results from Phase III SIMPADICO Trial in Peripheral Arterial Disease
HSMN NewsFeed - 31 Jan 2006
Bayer Diagnostics Announces First Fully-Automated High Sensitivity and High Precision Troponin Assays
Bayer Diagnostics Announces First Fully-Automated High Sensitivity and High Precision Troponin Assays
Additional items found! 62

Members Archive contains
62 additional stories matching:
acute coronary syndromes
(Password required)
acute coronary syndromes
(Password required)